scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00125-003-1247-9 |
P953 | full work available at URL | https://link.springer.com/content/pdf/10.1007/s00125-003-1247-9.pdf |
http://link.springer.com/article/10.1007/s00125-003-1247-9/fulltext.html | ||
http://link.springer.com/content/pdf/10.1007/s00125-003-1247-9.pdf | ||
http://link.springer.com/content/pdf/10.1007/s00125-003-1247-9 | ||
P698 | PubMed publication ID | 14595542 |
P5875 | ResearchGate publication ID | 9027574 |
P2093 | author name string | F. Kramer | |
K. E. Bornfeldt | |||
C. B. Renard | |||
B. Askari | |||
L. A. Suzuki | |||
P2860 | cites work | Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins | Q24292994 |
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells | Q28367258 | ||
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex | Q28577438 | ||
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice | Q28588806 | ||
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction | Q28678358 | ||
How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? | Q33783971 | ||
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. | Q33901974 | ||
Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats | Q33910543 | ||
Hypertriglyceridemia and the fibrate trials | Q34086718 | ||
Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. | Q34113238 | ||
Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu | Q34124460 | ||
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation | Q34133504 | ||
Advanced glycation end-products: a review | Q34196489 | ||
Distinct requirements for Ras oncogenesis in human versus mouse cells | Q34787097 | ||
Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options | Q34800437 | ||
Central role of RAGE-dependent neointimal expansion in arterial restenosis | Q34890522 | ||
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings | Q35009768 | ||
Diabetes mellitus and macrovascular complications. An epidemiological perspective | Q35373989 | ||
Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody | Q35798371 | ||
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus | Q35824553 | ||
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. | Q37308593 | ||
Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype | Q37375131 | ||
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production | Q38338991 | ||
DNA content histogram and cell-cycle analysis. | Q40597100 | ||
Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells | Q40864542 | ||
The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family | Q40877102 | ||
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry | Q42048767 | ||
A comparative study of the activation of protein kinase C alpha by different diacylglycerol isomers. | Q42073197 | ||
Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis | Q42493807 | ||
Linoleic acid and oleic acid increase the endothelin-1 binding and action in cultured rat aortic smooth muscle cells | Q42496410 | ||
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Q43565214 | ||
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | Q43566166 | ||
Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells | Q43622534 | ||
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. | Q43633661 | ||
Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
Human arterial smooth muscle cells rapidly deplete cell culture media of glucose | Q43694766 | ||
Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth. | Q43824032 | ||
Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells | Q44077331 | ||
Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile | Q44168286 | ||
Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells | Q46670261 | ||
Comparison of lipid fatty acids on a concentration basis vs weight percentage basis in patients with and without coronary artery disease or diabetes. | Q47395516 | ||
Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. | Q50504384 | ||
Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. | Q51552874 | ||
Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica | Q58394972 | ||
Methylglyoxal-modified arginine residues — a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells | Q60786650 | ||
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE | Q63433994 | ||
The fatty acid composition of triglycerides in arteries, depot fat and serum of amputated diabetics | Q67690740 | ||
Direct transesterification of all classes of lipids in a one-step reaction | Q70032561 | ||
Determination of free amino groups in proteins by trinitrobenzenesulfonic acid | Q70066383 | ||
Increased Adhesion of Erythrocytes to Endothelial Cells in Diabetes Mellitus and Its Relation to Vascular Complications | Q70804096 | ||
Effect of glycated collagen on proliferation of human smooth muscle cells in vitro | Q71557589 | ||
N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins | Q72030217 | ||
Distribution of plasma proteins across the human aortic wall Barrier functions of endothelium and internal elastic lamina | Q72626406 | ||
Serum fatty acid profiles in type I and type II diabetes: metabolic alterations of fatty acids of the main serum lipids | Q72714413 | ||
The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells | Q73070900 | ||
Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products | Q73086065 | ||
Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis | Q73107361 | ||
The effect of hyperlipidemia on serum fatty acid composition in type 2 diabetics | Q73786653 | ||
Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells | Q74423561 | ||
Fatty acid composition of phospholipids and neutral lipids from human diabetic small arteries and veins by a new TLC method | Q74670760 | ||
Diabetic dyslipidaemia | Q77147528 | ||
Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin | Q77650671 | ||
Chemical modification of proteins by methylglyoxal | Q77659598 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | internal medicine | Q11180 |
P304 | page(s) | 1676-1687 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells | |
P478 | volume | 46 |
Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
Q35863365 | Distinct regulation of stearoyl-CoA desaturase 1 gene expression by cis and trans C18:1 fatty acids in human aortic smooth muscle cells |
Q38777318 | Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology |
Q42471737 | Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding |
Q85217100 | Key fatty acid combinations define vascular smooth muscle cell proliferation and viability |
Q42212895 | Lipid metabolic pathways as lung cancer therapeutic targets: a computational study |
Q46192256 | Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways |
Q30439262 | Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology |
Q36118148 | Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway |
Q33642252 | Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. |
Q37815571 | Technologies for continuous glucose monitoring: current problems and future promises |
Q36508728 | The retinol dehydrogenase Rdh10 localizes to lipid droplets during acyl ester biosynthesis |
Search more.